The Anova Health Institute and Health4Men join with researchers and activists around the world in welcoming the recent research findings about HIV prevention in gay and bisexual men. The iPrEx results, published by the New England Journal of Medicine, have been welcomed as a constructive first step towards using antiretroviral treatment as part of prevention and have been cautiously lauded by US President Barack Obama.
The current study explored the use of ARV medication to prevent HIV infection, referred to as pre-exposure prophylaxis (PREP). Health4Men continues to supply free post-exposure prophylaxis (PEP) to MSM following high-risk exposure to the HI virus. Significantly, PEP must be initiated within 72 hours of the exposure.